| EDITORIAL |
|
| Year : 2017 | Volume
: 32
| Issue : 1 | Page : 11-12 |
|
|
Specificity of 68Ga-PSMA PET/CT for prostate cancer - myths and reality
Arun Sasikumar
Consultant Nuclear Medicine and PET/CT, KIMS-DDNMRC, KIMS hospital North Block, Anayara P.O, Thiruvananthapuram, Kerala, India
Correspondence Address:
Arun Sasikumar
Consultant Nuclear Medicine and PET/CT, KIMS-DDNMRC, KIMS hospital North Block, Anayara P.O, Thiruvananthapuram, Kerala
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-3919.198449
|
|
|
68Ga-PSMA ligand PET/CT for imaging prostate cancer is a novel imaging technique, which is rapidly gaining popularity. Sufficient evidence has been accumulated in literature regarding the usefulness of 68Ga-PSMA PET/CT in prostate cancer. Recently literature regarding the localization of 68Ga-PSMA PET/CT imaging in non-prostatic malignancies is also published, thus questioning the specificity of the tracer with regards to prostate cancer. This commentary tries to address the issue of specificity of 68Ga-PSMA PET/CT and its relevance in imaging prostate cancer. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
